Molnupiravir has major safety concerns: ICMR chief

New Delhi, Jan 5: ICMR Chief Dr Balram Bhargava said on Wednesday that Covid antiviral drug Molnupiravir has major safety concerns and has not been included in the national protocol for treatment of coronavirus. During a press briefing, he said the

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News